Patient Guide: A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 12 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06189391
Status: 🟢 Enrolling Now
Condition: Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Phase: PHASE1

Where You Can Participate

This study is available at 12 locations across the country.

Top locations include:
  • • Beijing, Beijing Municipality
  • • Beijing, Beijing Municipality
  • • Xiameng, Fujian
  • • And 9 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101) - Join Clinical Trial NCTNCT06189391

How to Join This Clinical Trial - NCTNCT06189391

Learn how to participate in this PHASE1 trial studying an investigational therapy for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06189391 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 12 locations. Find a study site near you:

Clinical Research Site

Beijing, Beijing Municipality 100071 - China

Status: RECRUITING

Clinical Research Site

Beijing, Beijing Municipality 100142 - China

Status: RECRUITING

Clinical Research Site

Xiameng, Fujian 361000 - China

Status: RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510060 - China

Status: RECRUITING

Clinical Research Site

Shijiazhuang, Hebei 050035 - China

Status: RECRUITING

Clinical Research Site

Zhengzhou, Henan 450000 - China

Status: RECRUITING

Clinical Research Site

Zhengzhou, Henan 451161 - China

Status: RECRUITING

Clinical Research Site

Nanchang, Jiangxi 330029 - China

Status: RECRUITING

Clinical Research Site

Jinan, Shandong 250117 - China

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Shanghai, Shanghai Municipality 200120 - China

Status: RECRUITING

And 2 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships